Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-23A

IL-23A

Brief Information

Name:Interleukin-23
Target Synonym:Interleukin-23
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:15
Lastest Research Phase:Approved

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Ustekinumab CNTO-1275; C-340; AVT-04 Approved 喜达诺, Stelara United States Plaque psoriasis Janssen Biotech Inc 2009-09-25 Multiple Sclerosis; Dermatitis, Atopic; Plaque psoriasis; Crohn Disease; Common Variable Immunodeficiency; Uveitis; Hidradenitis Suppurativa; Arthritis, Psoriatic; Colitis, Ulcerative; Lupus Erythematosus, Systemic; Takayasu Arteritis; Psoriasis; Liver Cirrhosis, Biliary; Arthritis, Juvenile; Ichthyosis; Sjogren's Syndrome; Pouchitis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Dermatomyositis; Non-radiographic axial spondyloarthritis; Polymyositis; Diabetes Mellitus, Type 1 Details
Ustekinumab biosimilar(Amgen) ABP-654 Approved Amgen Inc Wezlana, WEZLANA United States Arthritis, Psoriatic; Plaque psoriasis; Colitis, Ulcerative; Crohn Disease Amgen Inc 2023-10-31 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab CNTO-1275; C-340; AVT-04 Approved 喜达诺, Stelara United States Plaque psoriasis Janssen Biotech Inc 2009-09-25 Multiple Sclerosis; Dermatitis, Atopic; Plaque psoriasis; Crohn Disease; Common Variable Immunodeficiency; Uveitis; Hidradenitis Suppurativa; Arthritis, Psoriatic; Colitis, Ulcerative; Lupus Erythematosus, Systemic; Takayasu Arteritis; Psoriasis; Liver Cirrhosis, Biliary; Arthritis, Juvenile; Ichthyosis; Sjogren's Syndrome; Pouchitis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Dermatomyositis; Non-radiographic axial spondyloarthritis; Polymyositis; Diabetes Mellitus, Type 1 Details
Ustekinumab biosimilar(Amgen) ABP-654 Approved Amgen Inc Wezlana, WEZLANA United States Arthritis, Psoriatic; Plaque psoriasis; Colitis, Ulcerative; Crohn Disease Amgen Inc 2023-10-31 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
anti-cancer mRNA therapeutics (Moderna Therapeutics) mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Lymphoma, Non-Hodgkin; Lymphoma; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Ustekinumab Biosimilar(Celltrion) CT-P43 Phase 3 Clinical Celltrion Inc Psoriasis Details
SOR-102 SOR-102 Phase 1 Clinical Sorriso Pharmaceuticals Inc Inflammatory Bowel Diseases; Colitis, Ulcerative Details
LY-900021 LY-900021 Phase 1 Clinical Halozyme Therapeutics Inc, Eli Lilly And Company Details
IL-23/CGRP bispecific antibody (Lilly) Phase 1 Clinical Eli Lilly And Company Autoimmune Diseases Details
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) Phase 1 Clinical Neuclone, Serum Institute Of India Ltd Autoimmune Diseases Details
Ustekinumab biosimilar (BioFactura) BFI-751 Phase 1 Clinical BioFactura Australia Pty Ltd Psoriasis Details
Ustekinumab Biosimilar (qyuns) QX-001-S; HDM-3001; QX-001S Phase 3 Clinical Qyuns Therapeutics Co Ltd Psoriasis; Plaque psoriasis Details
Brazikumab AMG-139; MEDI-2070; Anti-IL-23-MAb (Amgen) Phase 2 Clinical Amgen Inc Inflammatory Bowel Diseases; Psoriasis; Colitis, Ulcerative; Crohn Disease Details
Ustekinumab biosimilar(CSPC Pharma) SYSA-1902 Phase 3 Clinical Jushi Biopharmaceutical Co Ltd Psoriasis; Plaque psoriasis Details
Ustekinumab biosimilar(Formycon) FYB-202 Phase 3 Clinical Formycon Psoriasis Details
Kagocel Clinical Nearmedic Plus Llc Respiratory Tract Infections; Respirovirus Infections; Influenza, Human Details
Ustekinumab biosimilar(Rani Therapeutics) RT-111 Phase 1 Clinical Rani Therapeutics Llc Psoriasis Details
anti-cancer mRNA therapeutics (Moderna Therapeutics) mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Lymphoma, Non-Hodgkin; Lymphoma; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Ustekinumab Biosimilar(Celltrion) CT-P43 Phase 3 Clinical Celltrion Inc Psoriasis Details
SOR-102 SOR-102 Phase 1 Clinical Sorriso Pharmaceuticals Inc Inflammatory Bowel Diseases; Colitis, Ulcerative Details
LY-900021 LY-900021 Phase 1 Clinical Halozyme Therapeutics Inc, Eli Lilly And Company Details
IL-23/CGRP bispecific antibody (Lilly) Phase 1 Clinical Eli Lilly And Company Autoimmune Diseases Details
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) Phase 1 Clinical Neuclone, Serum Institute Of India Ltd Autoimmune Diseases Details
Ustekinumab biosimilar (BioFactura) BFI-751 Phase 1 Clinical BioFactura Australia Pty Ltd Psoriasis Details
Ustekinumab Biosimilar (qyuns) QX-001-S; HDM-3001; QX-001S Phase 3 Clinical Qyuns Therapeutics Co Ltd Psoriasis; Plaque psoriasis Details
Brazikumab AMG-139; MEDI-2070; Anti-IL-23-MAb (Amgen) Phase 2 Clinical Amgen Inc Inflammatory Bowel Diseases; Psoriasis; Colitis, Ulcerative; Crohn Disease Details
Ustekinumab biosimilar(CSPC Pharma) SYSA-1902 Phase 3 Clinical Jushi Biopharmaceutical Co Ltd Psoriasis; Plaque psoriasis Details
Ustekinumab biosimilar(Formycon) FYB-202 Phase 3 Clinical Formycon Psoriasis Details
Kagocel Clinical Nearmedic Plus Llc Respiratory Tract Infections; Respirovirus Infections; Influenza, Human Details
Ustekinumab biosimilar(Rani Therapeutics) RT-111 Phase 1 Clinical Rani Therapeutics Llc Psoriasis Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message